Nicholas Peters reports 1,161,049 shares (8.65%) of QHSLab
QHSLab, Inc. reports a Schedule 13G showing beneficial ownership of 8.65% represented by 1,161,049 shares of Common Stock.
Rhea-AI Filing Summary
QHSLab, Inc. reports a Schedule 13G showing beneficial ownership of 8.65% represented by 1,161,049 shares of Common Stock. The filing lists Nicholas Peters as the beneficial owner with sole and shared voting and dispositive power over 1,161,049 shares.
The filing is signed by Nicholas Peters and dated 02/09/2026.
Positive
- None.
Negative
- None.
Insights
Single investor reports an 8.65% stake with full voting and dispositive authority.
The filing shows Nicholas Peters beneficially owns 1,161,049 shares, representing 8.65% of the class, and lists both sole and shared voting and dispositive power for the same amount. This indicates control claims over the position rather than passive custody.
Timing is explicit: the signature date is 02/09/2026. Future disclosures may clarify whether this stake is held for investment or other purposes.
A disclosed 8.65% holding could be noticeable for float and block trading considerations.
The excerpt quantifies the position as 1,161,049 common shares and repeats the voting/dispositive counts identically, suggesting consolidated control. The cash‑flow treatment or planned transactions are not described in the excerpt.
Market impact depends on the company's float and subsequent filings; watch for any Form 4 or Schedule 13D amendments that change intent or activity.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does the Schedule 13G for QHSLab (USAQ) show voting or disposition authority?
What date is on the QHSLab (USAQ) Schedule 13G filing by Nicholas Peters?
Is the reported stake in QHSLab (USAQ) a majority or minority position?
Where is QHSLab's principal office listed in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.